tradingkey.logo

Apyx Medical Corp

APYX

1.765USD

+0.015+0.86%
Market hours ETQuotes delayed by 15 min
66.71MMarket Cap
LossP/E TTM

Apyx Medical Corp

1.765

+0.015+0.86%
More Details of Apyx Medical Corp Company
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and OEM. The Advanced Energy segment's product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It is focused on the cosmetic surgery market where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue to achieve their desired results. Its product lines consist of a multifunction generator, a handpiece and a supply of helium gas. The OEM segment leverages its expertise in the design, development and manufacturing of electrosurgical equipment and medical devices by producing generators, medical devices and related accessories for medical device manufacturers through original equipment manufacturing agreements, as well as start-up companies with the need for its energy-based designs.
Company Info
Ticker SymbolAPYX
Company nameApyx Medical Corp
IPO dateJul 22, 1983
CEOMr. Charles D. Goodwin, II
Number of employees220
Security typeOrdinary Share
Fiscal year-endJul 22
Address5115 Ulmerton Rd
CityCLEARWATER
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code33760-4004
Phone18005372790
Websitehttps://apyxmedical.com/
Ticker SymbolAPYX
IPO dateJul 22, 1983
CEOMr. Charles D. Goodwin, II
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Domestic
6.74M
71.51%
International
2.69M
28.49%
By Business
By Region
No Data
Shareholding Stats
Updated: Mon, Jul 28
Updated: Mon, Jul 28
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
9.24%
Vanderfelt (William Weeks)
8.36%
Archon Capital Management LLC
8.24%
Royce Investment Partners
6.83%
Vizirgianakis (Stavros G)
4.62%
Other
62.70%
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
9.24%
Vanderfelt (William Weeks)
8.36%
Archon Capital Management LLC
8.24%
Royce Investment Partners
6.83%
Vizirgianakis (Stavros G)
4.62%
Other
62.70%
Shareholder Types
Shareholders
Proportion
Hedge Fund
18.35%
Individual Investor
14.56%
Investment Advisor
13.15%
Investment Advisor/Hedge Fund
11.82%
Private Equity
0.40%
Research Firm
0.07%
Family Office
0.05%
Other
41.60%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
116
22.05M
58.35%
-4.12M
2025Q1
125
22.61M
59.94%
-6.15M
2024Q4
130
22.74M
56.04%
-3.63M
2024Q3
136
20.12M
55.21%
-8.55M
2024Q2
151
21.12M
58.12%
-8.52M
2024Q1
177
21.34M
61.14%
-7.38M
2023Q4
188
22.63M
64.87%
-7.08M
2023Q3
183
23.85M
68.61%
-6.50M
2023Q2
175
23.83M
68.55%
-8.83M
2023Q1
178
25.32M
73.20%
-1.68M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Nantahala Capital Management, LLC
3.49M
9.24%
+235.19K
+7.22%
Jun 23, 2025
Vanderfelt (William Weeks)
3.16M
8.36%
--
--
Jun 23, 2025
Archon Capital Management LLC
3.12M
8.24%
-181.46K
-5.50%
Jun 23, 2025
Royce Investment Partners
2.58M
6.83%
+57.02K
+2.26%
Jun 23, 2025
Vizirgianakis (Stavros G)
1.75M
4.62%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.48M
3.9%
--
--
Mar 31, 2025
Silverberg Bernstein Capital Management, LLC
646.57K
1.71%
+75.34K
+13.19%
Mar 31, 2025
Horizon Kinetics LLC
615.00K
1.63%
--
--
Mar 31, 2025
Commonwealth Financial Network
585.54K
1.55%
+58.48K
+11.10%
Mar 31, 2025
Worth Venture Partners, LLC
518.20K
1.37%
+55.59K
+12.02%
Dec 31, 2023
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
Avantis US Equity ETF
Proportion0%
Invesco NASDAQ Future Gen 200 ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI